Clinical Trial Update: A Postmarket Surveillance Study of the Paradigm Spine Dynamic Stabilization System (DSS) [NA]

View source ↗

Summary

A postmarket surveillance study of the Paradigm Spine Dynamic Stabilization System (DSS) was terminated; results were posted in 2019.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Kyphosis
• Neurologic Deficits
• Pseudarthrosis
• Spondylolisthesis

Drugs mentioned

• Paradigm Spine Dynamic Stabilization System (DSS)

Snippet

Sponsor: Paradigm Spine | Conditions: Spondylolisthesis, Neurologic Deficits | NA | Status: TERMINATED | Results posted: 2019-10-15